用于癌症相关性视网膜病变的一种缓释地塞米松植入物。
A slow-release dexamethasone implant for cancer-associated retinopathy.
机构信息
Department of Ophthalmology, Otorhinolaryngology and Head and Neck Surgery Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo, Ribeirão Preto, SP, Brazil.
Ocular Oncology Service, Bascom Palmer Eye Institute and Sylvester Cancer Center, University of Miami, Miami, FL, USA.
出版信息
Arq Bras Oftalmol. 2023 Mar-Apr;86(2):171-174. doi: 10.5935/0004-2749.20230006.
This case report aims to show the anatomical and functional results of a patient diagnosed as having cancer-associated retinopathy treated with a controlled-release dexamethasone implant (Ozurdex). Anatomical outcomes were assessed using spectral domain optical coherence tomography; and functional outcomes, by measuring visual acuity, microperimetry, and mutifocal electroretinography. The follow-up period was 1 year.
本病例报告旨在展示一位被诊断为患有癌症相关性视网膜病变的患者接受控释型地塞米松植入物（Ozurdex）治疗后的解剖和功能结果。使用谱域光学相干断层扫描评估解剖学结果；通过测量视力、微视野和多焦视网膜电图评估功能结果。随访时间为 1 年。
Zotero 插件